MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gait disorders: Treatment"

  • MDS Virtual Congress 2021

    Reducing anxiety improves freezing of gait in Parkinson’s disease patients

    A. Al Jaja, K. Seergobin, J. Grahn, P. Macdonald (London, Canada)

    Objective: Investigate the effect of reducing anxiety using a known anxiolytic, alprazolam, on FOG symptoms severity and frequency. This reduction, in turn, might reduce the…
  • MDS Virtual Congress 2021

    Pilot study to assess gait-related motor symptoms in Parkinson’s disease by using a unique passive monitoring wearable technology

    G. Monneret, D. Jacobs, L. Farid, A. Post, C. Moreau, G. Baille (Paris, France)

    Objective: The objective of this pilot study is to present data demonstrating the ability of a wearable medical device combining plantar pressure sensors, accelerometers, and…
  • MDS Virtual Congress 2021

    FREEZESTEP = DALFLEX

    D. Dalal, A. Mehta, P. R, M. Javali, P. Acharya (Bengaluru, India)

    Objective: Freezing of gait(FOG) is defined as a brief, episodic absence or marked reduction of forward progression of the feet despite the intention to walk.…
  • MDS Virtual Congress 2021

    Efficacy of the ankle bracelet-laser to improve gait in Parkinson disease (PD).

    P. Ruthiraphong, C. Ratanasutiranont, K. Srisilpa (Bangkok, Thailand)

    Objective: To assess the efficacy of the ankle bracelet-laser in improving gait parameters and functional performance in Parkinson patients with freezing of gait (FOG) Background:…
  • MDS Virtual Congress 2021

    Immune-mediated movement disorder as a Rare Manifestation of a Sarcoma

    K. Block, S. Syed, A. Boyle, S. Chandra (Houston, USA)

    Objective: We describe a rare case of a young woman with an immune-mediated movement disorder (paraneoplastic Stiff Person Syndrome) associated with a mediastinal liposarcoma. This…
  • MDS Virtual Congress 2021

    Automated Mechanical Peripheral Stimulation for walking rehabilitation in Parkinson’s disease: a systematic review

    T. Corbet, SN. Edd (Epalinges, Switzerland)

    Objective: This systematic review aims to assess the efficacy of automated mechanical peripheral stimulation (AMPS) as a therapy for Parkinson’s disease (PD). Background: One of…
  • MDS Virtual Congress 2020

    Effects of onabotulinum toxin A on balance and gait in Parkinson’s disease with foot dystonia: A case series study

    P. Huang, YY. Li, P. Huang, Q. Xiao, Y. Wang, S. Chen, S.D Chen, J. Liu, Y.W Wu (Shanghai, China)

    Objective: To investigate the effectiveness of botulinum toxin (BoNT) in reducing the severity of dystonia and improving gait and balance in Parkinson’s disease (PD) patients…
  • MDS Virtual Congress 2020

    Spinal Cord Stimulation Improves Gait velocity but Not Freezing Episodes in PD Patient with Prior GPi-DBS: A Case Report

    L.B Wang, Y.X Pan, T. Wang, C-C. Zhang, D.Y Li (Shanghai, China)

    Objective: To examine the effects of SCS on gait disturbance in PD patients with prior GPi-DBS. Background: Previous studies have suggested the safety and efficacy…
  • MDS Virtual Congress 2020

    Anticholinergic Burden in Parkinson’s Disease Patients in India – A Hospital Based Study

    A. Saini, R. Rajan, R. Anandapadmanabhan, V. Venogopalan, A. Gupta, B. Verma, N. Choudhary, R. Bhatia, M. Singh, A. Srivastava, P. Srivastava (New Delhi, India)

    Objective: To determine the cumulative anticholinergic burden in Indian Parkinson’s disease (PD) patients and to correlate the same with cognitive impairment and gait disturbance. Background:…
  • MDS Virtual Congress 2020

    Correlations between amantadine usage, gait, and cognition in PSP: a post hoc analysis of the davunetide trial

    M. Dale, B. Brumbach, A. Hiller (Portland, OR, USA)

    Objective: Amantadine anecdotally improves gait and balance in PSP, potentially by increasing alertness, but there are no definitive data to support this observation. We investigated…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 33
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley